Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Roy Herbst MD, PhD

Roy S. Herbst MD, PhD

Ensign Professor of Medicine (Medical Oncology) and Professor of Pharmacology; Chief of Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital at Yale-New Haven; Associate Director for Translational Research, Yale Cancer Center; Translational Working Group Leader, Thoracic Oncology Program, Yale Cancer Center, New Haven, CT

Recent Contributions to PracticeUpdate:

  1. Roy Herbst on Proton Therapy vs Conventional Radiation Therapy in the Treatment of Early NSCLC
  2. Advances in Immunotherapy for Small Cell Lung Cancer
  3. Lung Cancer Overview From ASCO: Future Directions
  4. Integrating Immunotherapy Into Small-Cell Lung Cancer Treatment: A Review of New Data
  5. Practical Aspects of Immunotherapy for Thoracic Cancers

Most Read This Week

Recently Updated